Photo Quiz

Scalded Mouth with Headache



FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.


FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.

Am Fam Physician. 2008 May 1;77(9):1307-1309.

A 60-year-old man presented after burning the roof of his mouth on hot soup five days earlier. The burned sensation resolved after one day; however, a couple of days later, he noticed tingling on the right side of the hard palate that progressed to a scalded sensation. This was accompanied by tenderness along the right temporal area and discomfort below the right ear. He denied a history of oral lesions.

Examination revealed erythema that was confined to the right side of the hard palate with multiple ulcerations and vesicles (Figures 1 and 2). Although mild redness and swelling were noted just below the right ear, no skin lesions were present.

Figure 1.

View Large


Figure 1.


Figure 1.

Figure 2.

View Large


Figure 2.


Figure 2.

Question

Based on the patient's history and physical examination, which one of the following is the most likely diagnosis?

A. Herpes zoster (shingles).

B. Intraoral herpes simplex virus infection.

C. Primary syphilis.

D. Recurrent aphthous stomatitis.

E. Ulcers from thermal trauma.

Discussion

The answer is A: herpes zoster (shingles). The presence of multiple vesicles that vary in size and are confined to the right side of the hard palate (i.e., cranial nerve V2 distribution) accompanied by neuralgia and erythema in ipsilateral cutaneous portions of the right trigeminal nerve suggests herpes zoster over oral herpes simplex virus (HSV) infection. HSV infection is also less likely in this patient because he has no history of oral ulcers. However, herpes zoster cannot be differentiated from HSV infection based on clinical findings alone because HSV lesions can occur unilaterally and be indistinguishable from those caused by the varicella zoster virus. A more definitive clinical diagnosis of herpes zoster requires the presence of an associated cutaneous herpetiform rash in the appropriate distribution of the affected nerve.

Laboratory testing of affected tissue or fluid from the vesicles is needed for a conclusive herpes zoster diagnosis. A positive Tzanck smear result showing multinucleated giant cells on a scraping from a vesicle base rules out other causes of oral lesions, but does not differentiate herpes zoster from HSV.1 A polymerase chain reaction (PCR) assay is the most sensitive test for identifying HSV and varicella zoster virus; it can detect viral DNA from vesicle fluid swabs, crusts, Tzanck smear debris, and tissue specimens fixed in formalin. Compared with culture, PCR assays are 22 percent more sensitive for HSV and 91 percent more sensitive for varicella zoster virus, with 100 percent specificity for each virus.2,3 Additionally, real-time PCR assays now offer rapid turnaround times at costs similar to culture.24

The primary therapeutic goals for herpes zoster are to shorten the duration of initial symptoms and to decrease the incidence and extent of postherpetic neuralgia. Acyclovir (Zovirax), valacyclovir (Valtrex), and famciclovir (Famvir) are available for the treatment of herpes zoster. Current evidence supports using these agents to hasten resolution of lesions and acute pain, as well as to attenuate the development of postherpetic neuralgia. Evidence from randomized, double-blind trials suggests that valacyclovir and famciclovir are more effective and require less frequent dosing than acyclovir.59 However, generic acyclovir, 800 mg five times daily, may be considered when antiviral therapy is precluded because of cost.

Antiviral therapy should be initiated within 72 hours of the onset of the rash or if new lesions continue to form. The benefit of adding oral steroids to antiviral treatment is unclear and potentially harmful. Acyclovir combined with steroids does not reduce the incidence or duration of postherpetic neuralgia.9

The oral lesions in this patient differ significantly from those typically associated with primary syphilis. With primary syphilis, a papule develops on loose, nonkeratinized mucosa, then breaks down into a large, painless, solitary ulcer with a raised border.

Recurrent aphthous stomatitis (canker sores), HSV, or varicella zoster virus can appear as grouped or clustered oral ulcerations. However, recurrent aphthous stomatitis does not have a vesicular phase and usually appears as a single ulcer or a small number of ulcers. Aphthous stomatitis usually occurs on loose, nonkeratinized mucosal surfaces such as buccal or labial mucosa, the floor of the mouth, and the ventral surface of the tongue.10 Conversely, herpetic ulcers, which are usually multiple and have a vesicular stage, affect immovable, keratinized mucosa, including the hard palate, attached gingivae, and dorsal tongue.

Keratinized mucosa is an integral part of the masticatory apparatus; thus, it is routinely subject to oral trauma, such as burns from hot food. Ulcers from thermal injuries often affect the keratinized surfaces, but are unlikely to cause multiple, discrete ulcerations.

Characteristics of Different Types of Acute Oral Ulcerations

Type of ulceration Location Size Morphology Vesicular phase Pain Frequency Recurrence Dermatomal pattern

Herpes zoster (shingles)

Hard or soft palate(cranial nerve V) or inner cheek (V3)

Usually small and discrete (1 to 2 mm)

Multiple, usually grouped

Initially

More severe than HSV ulcers

Rare

Rare

Typical

HSV infection

Immovable, keratinized (masticatory) mucosa

Usually small and discrete (1 to 2 mm)

Multiple, usually grouped

Initially

Mild

Uncommon intraorally

In up to 40 percent of patients

No

Primary syphilis

Loose, nonkeratinized mucosa

Large (3 to 20 mm)

Usually solitary with a raised border

None; begins as a papule

None

Uncommon

Rare

No

Recurrent aphthous stomatitis

Loose, nonkeratinized mucosa

Typically larger than an HSV ulcer

Usually solitary or few in number; may be clustered (herpetiform)

None

Sometimes intense

Common

Common

No

Minor (80 percent of cases), 1 to 5 mm; major (10 percent of cases), 5 to 15 mm; herpetiform, 1 to 2 mm

Thermal trauma

Usually keratinized mucosa

Usually larger and nondiscrete

Variable

None

Mild

Common

With recurrent trauma

No


HSV = herpes simplex virus.

Information from Hairston BR, Bruce AJ, Rogers RS III. Viral diseases of the oral mucosa. Dermatologic Clin. 2003;21(1)17–32; Fauci AS, Braunwald E, Kasper DL, et al., eds. Harrison's Principles of Internal Medicine. 17th ed. New York, NY: McGraw-Hill; 2006; and Habif TP. Clinical Dermatology. A Color Guide to Diagnosis and Therapy. 4th ed. Philadelphia, Pa.: Mosby; 2004.

Characteristics of Different Types of Acute Oral Ulcerations

View Table

Characteristics of Different Types of Acute Oral Ulcerations

Type of ulceration Location Size Morphology Vesicular phase Pain Frequency Recurrence Dermatomal pattern

Herpes zoster (shingles)

Hard or soft palate(cranial nerve V) or inner cheek (V3)

Usually small and discrete (1 to 2 mm)

Multiple, usually grouped

Initially

More severe than HSV ulcers

Rare

Rare

Typical

HSV infection

Immovable, keratinized (masticatory) mucosa

Usually small and discrete (1 to 2 mm)

Multiple, usually grouped

Initially

Mild

Uncommon intraorally

In up to 40 percent of patients

No

Primary syphilis

Loose, nonkeratinized mucosa

Large (3 to 20 mm)

Usually solitary with a raised border

None; begins as a papule

None

Uncommon

Rare

No

Recurrent aphthous stomatitis

Loose, nonkeratinized mucosa

Typically larger than an HSV ulcer

Usually solitary or few in number; may be clustered (herpetiform)

None

Sometimes intense

Common

Common

No

Minor (80 percent of cases), 1 to 5 mm; major (10 percent of cases), 5 to 15 mm; herpetiform, 1 to 2 mm

Thermal trauma

Usually keratinized mucosa

Usually larger and nondiscrete

Variable

None

Mild

Common

With recurrent trauma

No


HSV = herpes simplex virus.

Information from Hairston BR, Bruce AJ, Rogers RS III. Viral diseases of the oral mucosa. Dermatologic Clin. 2003;21(1)17–32; Fauci AS, Braunwald E, Kasper DL, et al., eds. Harrison's Principles of Internal Medicine. 17th ed. New York, NY: McGraw-Hill; 2006; and Habif TP. Clinical Dermatology. A Color Guide to Diagnosis and Therapy. 4th ed. Philadelphia, Pa.: Mosby; 2004.

Address correspondence to Brian H. Grimard, MD, at grimard.brian@mayo.edu. Reprints are not available from the authors.

Author disclosure: Nothing to disclose.

REFERENCES

1. Hairston BR, Bruce AJ, Rogers RS III. Viral diseases of the oral mucosa. Dermatologic Clin. 2003;21(1):17–32.

2. Espy MJ, Uhl JR, Mitchell PS, et al. Diagnosis of herpes simplex virus infections in the clinical laboratory by LightCycler PCR. J Clin Microbiol. 2000;38(2):795–799.

3. Espy MJ, Teo R, Ross TK, et al. Diagnosis of varicellazoster virus infections in the clinical laboratory by Light-Cycler PCR. J Clin Microbiol. 2000;38(9):3187–3189.

4. Espy MJ, Uhl JR, Sloan LM, et al. Real-time PCR in clinical microbiology: applications for routine laboratory testing [published correction appears in Clin Microbiol Rev. 2006;19(3):595]. Clin Microbiol Rev. 2006;19(1):165–256.

5. Beutner KR, Friedman DJ, Forszpaniak C, Andersen PL, Wood MJ. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother. 1995;39(7):1546–1553.

6. Tyring S, Barbarash RA, Nahlik JE, et al., for the Collaborative Famciclovir Herpes Zoster Study Group. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1995;123(2):89–96.

7. Wood MJ, Kay R, Dworkin RH, Soong SJ, Whitley RJ. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis. 1996;22(2):341–347.

8. Jackson JL, Gibbons R, Meyer G, Inouye L. The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia. A meta-analysis. Arch Intern Med. 1997;157(8):909–912.

9. Wareham D. Postherpetic neuralgia. http://www.clinicalevidence.bmj.com/ceweb/conditions/ind/0905/0905.jsp (subscription required). Accessed February 20, 2008.

10. Bruce AJ, Rogers RS III. Acute oral ulcers. Dermatol Clin. 2003;21(1):1–15.

The editors of AFP welcome submissions for Photo Quiz. Guidelines for preparing and submitting a Photo Quiz manuscript can be found in the Authors' Guide at http://www.aafp.org/afp/photoquizinfo. To be considered for publication, submissions must meet these guidelines. E-mail submissions to afpphoto@aafp.org.



Copyright © 2008 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


Article Tools

  • Print page
  • Share this page
  • AFP CME Quiz

Information From Industry

More in AFP

More in Pubmed

Navigate this Article